Insider Shareholders with Direct Ownership of Navidea Biopharmaceuticals, Inc. (NAVB)
This section provides a comprehensive overview of the insiders with direct ownership of Navidea Biopharmaceuticals, Inc. (NAVB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NAVIDEA BIOPHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Craig Dais
CHIEF FINANCIAL OFFICER |
973,633 | 0 | 973,633 $0 | 1 |
Nov 10, 2023
Added 50.0%
|
| 941,667 | 0 | 941,667 $0 | 2 |
Nov 16, 2023
Added 30.67%
|
|
| 866,667 | 0 | 866,667 $0 | 2 |
Nov 16, 2023
Added 32.47%
|
|
|
Malcolm G Witter
Director |
159,638 | 0 | 163,888 $0 | 23 |
Nov 30, 2022
Added 0.76%
|
|
Amit Bhalla
Director |
71,818 | 0 | 71,818 $0 | 17 |
Nov 30, 2022
Added 1.71%
|
|
Alexander L Cappello
Director |
67,727 | 0 | 67,727 $0 | 15 |
Nov 30, 2022
Added 1.81%
|
|
Michael Stanley Rosol
Chief Medical Officer |
48,878 | 0 | 55,725 $0 | 2 |
Sep 09, 2022
Added 18.92%
|
|
Agnieszka Winkler
Director |
33,600 | 0 | 33,600 $0 | 2 |
Nov 30, 2021
Added 3.59%
|
|
Thomas F Farb
Director |
33,425 | 0 | 33,425 $0 | 2 |
Nov 30, 2021
Added 3.6%
|
|
Joshua M. Wilson
Director |
30,000 | 0 | 30,000 $0 | 1 |
Nov 29, 2022
Added 50.0%
|
|
Sarah Kathryn Rouan
Director |
7,392 | 0 | 18,242 $0 | 2 |
Jun 30, 2021
Added 21.15%
|
|
Claudine Bruck
Director |
6,469 | 0 | 16,519 $0 | 2 |
Jun 30, 2021
Added 19.37%
|
|
Yehuda Michael Rice
Director |
2,500 | 0 | 12,500 $0 | 1 |
Jan 13, 2021
Added 16.67%
|
|
Adam D. Cutler
Director |
2,500 | 0 | 10,000 $0 | 1 |
Jan 13, 2021
Added 20.0%
|
| 23,774,415 | 3,260 | 0 $0 | 19 |
Nov 27, 2023
Reduced 100.0%
|